Financing ·
On June 10, 2026, NeOnc Technologies Holdings, Inc. entered into a Securities Purchase Agreement to sell up to…
NTHINeonc Technologies Holdings, Inc.
On June 10, 2026, NeOnc Technologies Holdings, Inc. entered into a Securities Purchase Agreement to sell up to $5,000,000 of Series A Convertible Preferred Stock to accredited investors in a private placement. The stock is priced at $833.34 per share, with up to 6,000 shares authorized. The company amended its Certificate of Incorporation to establish the Series A Preferred Stock, which ranks senior to common stock and is redeemable by the company within four months of issuance (with two one-month extension options). If not redeemed, shares become convertible into common stock at 80% of the lowest closing price during the five trading days prior to conversion, subject to a $1.00 floor and a 19.99% beneficial ownership limit. The company operates in the biotechnology industry, focusing on oncology therapeutics.